PGC cohort

Aliases

PGC disorder working groups, PGC samples, PGC2 report, PGC3 standards, Psychiatric Genomics Consortium, Psychiatric Genomics Consortium Phase 2

Related entities (53)

Mentioned in (28)

Papers in which this entity is mentioned.

• Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
• Predicting Alcohol-Related Memory Problems in Older Adults: A Machine Learning Study with Multi-Domain Features. (2023)
• Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. (2023)
• Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
• Genetic Influences on the Developing Young Brain and Risk for Neuropsychiatric Disorders. (2023)
• Mapping genomic loci implicates genes and synaptic biology in schizophrenia. (2022)
• Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality. (2021)
• Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. (2021)
• Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
• Genetics of substance use disorders in the era of big data. (2021)
• The association of polygenic risk for schizophrenia, bipolar disorder, and depression with neural connectivity in adolescents and young adults: examining developmental and sex differences. (2021)
• ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. (2020)
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
• Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders. (2019)
• Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
• Identification of common genetic risk variants for autism spectrum disorder. (2019)
• The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder. (2018)
• Psychiatric Genomics: An Update and an Agenda. (2018)
• Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. (2018)
• Translating genome-wide association findings into new therapeutics for psychiatry. (2016)
• Recent genetic findings in schizophrenia and their therapeutic relevance. (2015)
• Evaluating historical candidate genes for schizophrenia. (2015)
• Genetics and genomics of psychiatric disease. (2015)
• Live imaging-based model selection reveals periodic regulation of the stochastic G1/S phase transition in vertebrate axial development. (2014)
• A mega-analysis of genome-wide association studies for major depressive disorder. (2013)
• The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
• The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
• Genomewide association studies: history, rationale, and prospects for psychiatric disorders. (2009)

Merged raw entities (9)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.